365 related articles for article (PubMed ID: 32563945)
1. Emerging nanotherapeutics for antithrombotic treatment.
Zhao Z; Yang F; Zhang X; Sun J; He Z; Luo C
Biomaterials; 2020 Oct; 255():120200. PubMed ID: 32563945
[TBL] [Abstract][Full Text] [Related]
2. Application of Nanotechnology in Thrombus Therapy.
Zhou S; Zhao W; Hu J; Mao C; Zhou M
Adv Healthc Mater; 2023 Mar; 12(7):e2202578. PubMed ID: 36507827
[TBL] [Abstract][Full Text] [Related]
3. Application of nanotechnology in thrombus therapy.
Liao K; Wu Q; Li Y; Wu C; Zhou Y; Zeng Q
J Mater Chem B; 2023 Jun; 11(23):5043-5050. PubMed ID: 37211877
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology in inflammation: cutting-edge advances in diagnostics, therapeutics and theranostics.
Liu Y; Lin Z; Wang Y; Chen L; Wang Y; Luo C
Theranostics; 2024; 14(6):2490-2525. PubMed ID: 38646646
[TBL] [Abstract][Full Text] [Related]
5. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
[TBL] [Abstract][Full Text] [Related]
6. Dimeric prodrug-based nanomedicines for cancer therapy.
Li S; Shan X; Wang Y; Chen Q; Sun J; He Z; Sun B; Luo C
J Control Release; 2020 Oct; 326():510-522. PubMed ID: 32721523
[TBL] [Abstract][Full Text] [Related]
7. Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis.
Priya V; Viswanadh MK; Mehata AK; Jain D; Singh SK; Muthu MS
Nanomedicine (Lond); 2021 Jun; 16(13):1153-1176. PubMed ID: 33973818
[TBL] [Abstract][Full Text] [Related]
8. Boarding pyroptosis onto nanotechnology for cancer therapy.
Ban W; Chen Z; Zhang T; Du T; Huo D; Zhu G; He Z; Sun J; Sun M
J Control Release; 2024 Jun; 370():653-676. PubMed ID: 38735396
[TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-driven nanotherapeutics for cancer treatment.
Shan X; Li S; Sun B; Chen Q; Sun J; He Z; Luo C
J Control Release; 2020 Mar; 319():322-332. PubMed ID: 31917296
[TBL] [Abstract][Full Text] [Related]
10. Progress of nanomaterials in the treatment of thrombus.
Shen Y; Yu Y; Zhang X; Hu B; Wang N
Drug Deliv Transl Res; 2024 May; 14(5):1154-1172. PubMed ID: 38006448
[TBL] [Abstract][Full Text] [Related]
11. Navigating zinc-involved nanomedicine in oncotherapy.
Yao J; Zhang A; Qiu Y; Li Z; Wu X; Li Z; Wu A; Yang F
Nanoscale; 2023 Mar; 15(9):4261-4276. PubMed ID: 36756840
[TBL] [Abstract][Full Text] [Related]
12. Progress of thrombus formation and research on the structure-activity relationship for antithrombotic drugs.
Li X; Guo T; Feng Q; Bai T; Wu L; Liu Y; Zheng X; Jia J; Pei J; Wu S; Song Y; Zhang Y
Eur J Med Chem; 2022 Jan; 228():114035. PubMed ID: 34902735
[TBL] [Abstract][Full Text] [Related]
13. Promises of Nanotherapeutics in Obesity.
Ash GI; Kim D; Choudhury M
Trends Endocrinol Metab; 2019 Jun; 30(6):369-383. PubMed ID: 31126754
[TBL] [Abstract][Full Text] [Related]
14. Protein-Based Nanocarriers and Nanotherapeutics for Infection and Inflammation.
Nagar N; Naidu G; Mishra A; Poluri KM
J Pharmacol Exp Ther; 2024 Jan; 388(1):91-109. PubMed ID: 37699711
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence aids in development of nanomedicines for cancer management.
Tan P; Chen X; Zhang H; Wei Q; Luo K
Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
[TBL] [Abstract][Full Text] [Related]
16. Interfacially responsive electron transfer and matter conversion by polydopamine-mediated nanoplatforms for advancing disease theranostics.
Wang L; Zhang T; Xing Y; Wang Z; Xie X; Zhang J; Cai K
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1805. PubMed ID: 35474610
[TBL] [Abstract][Full Text] [Related]
17. Personalized Nanomedicine: A Revolution at the Nanoscale.
Fornaguera C; García-Celma MJ
J Pers Med; 2017 Oct; 7(4):. PubMed ID: 29023366
[TBL] [Abstract][Full Text] [Related]
18. Nanotherapeutics for Antimetastatic Treatment.
Yang F; Zhao Z; Sun B; Chen Q; Sun J; He Z; Luo C
Trends Cancer; 2020 Aug; 6(8):645-659. PubMed ID: 32448754
[TBL] [Abstract][Full Text] [Related]
19. Thrombus-Targeting Polymeric Nanocarriers and Their Biomedical Applications in Thrombolytic Therapy.
Guan Q; Dou H
Front Physiol; 2021; 12():763085. PubMed ID: 34916956
[TBL] [Abstract][Full Text] [Related]
20. Critical considerations for targeting colorectal liver metastases with nanotechnology.
Arshad U; Sutton PA; Ashford MB; Treacher KE; Liptrott NJ; Rannard SP; Goldring CE; Owen A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1588. PubMed ID: 31566913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
